Reduction observed in RSV-related hospitalizations in adults aged ≥60 years 1 An observed reduction in major adverse ...

Respiratory syncytial virus (RSV) vaccines were an estimated 79% effective against dangerous virus-related blood clots among ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

A vaccine currently being developed by a team at Université Laval could one day protect young children from three different diseases, including the dreaded respiratory syncytial virus (RSV). It would ...

RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D ...

Catalent and S.Biomedics today announced a strategic partnership to support the development and manufacturing of TED?A9, S.Biomedics' allogeneic pluripotent stem-cell-derived ventral midbrain?specific ...

City-wide Mold Busters initiative from the New York City Housing Authority (NYCHA) reduced asthma-related emergency department (ED) visits for public housing residents, according to new research being ...

A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...